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Two Cases of Co-Infection with Babesiosis and Lyme
Disease

Anthony DeCicco, MD, B. Niluk Peiris, MD, Cecilia Kelly, MD, Michael Latreille, MD and Donald Jungkind, PhD

Case 1
The patient is a 71-year-old female with past medical history
significant for hypothyroidism and hyperlipidemia who
presented to Thomas Jefferson University Hospital (TJUH) with
complaints of myalgias for 6 weeks duration. The patient stated
that she had begun an exercise program to lose weight and had
subsequently noticed body aches and increased fatigue. She had
presented to an outside hospital with these complaints, was
told that the etiology was musculoskeletal, and was prescribed
naproxen for pain relief. The pain did improve slightly with
the naproxen but she noticed a rash and hives after starting the
medication and stopped taking it. Her symptoms continued
for about 6 weeks and she decided to come to our emergency
department when she was unable to obtain an appointment
with her primary care physician. She also noted that 2 days prior
to admission she had an increase in her temperature to 100˚ F.
She had been feeling fevers since this time coupled with chills
and sweating. The fevers were not cyclic in nature.
On presentation the patient noted that her body aches
were diffuse and constant. The pain itself was a “dull” pain
and “soreness”. There was no radiation or exacerbating or
alleviating factors. There were no other associated symptoms
except the fevers mentioned above. She denied any joint pains
or swelling, as well as any tenderness to palpation of her muscles
or joints. She did note that she had mild nasal congestion but
no rhinorrhea, coughing, or shortness of breath. She also had
had “tea-colored” urine about 1 day prior to admission but no
dysuria. She denied any abdominal pains, constipation, nausea,
vomiting or diarrhea. Her review of systems was positive for
malaise, increased fatigue and headache, all noted above. She
denied any respiratory symptoms, abdominal symptoms or
urinary symptoms. There was no focal muscular pain, joint
pain, or swelling.
The patient had hypothyroidism controlled with levothyroxine,
hyperlipidemia controlled with ezetimibe, simvastatin and
Omega-3-acid ethyl esters, seasonal allergies controlled with
fexofenadine, and depression controlled with duloxetine. She
had been stable on these medications and there were no new
medications started. She was allergic to sulfamethoxazole/
trimethoprim and naproxen, with both causing a rash.
She originally immigrated to the United States from Columbia
in 1972 and had not travelled outside of the United States
recently. She denied any sick contacts. She worked as a weaver
in the past but currently worked as a home health aide at a farm
in rural Pennsylvania. She did report tick and mosquito bites
in the past but did not recall any new rashes on her body. Her
family history was significant for a mother with hepatocellular
carcinoma, deceased, and a father with end-stage renal disease,
also deceased.
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Her physical exam was positive for scant bibasilar crackles
that cleared with coughing. She did not have any lymphadenopathy. Her skin exam revealed no rashes or target lesions. She
had full strength in all her extremities and did not have a gait
disturbance. She did not have any meningeal signs or any focal
neurological deficits.
Given the nature of her symptoms, the acute nature of her
fevers, and the time of year, influenza was initially suspected.
There was also a concern for subacute endocarditis and as
a result she was admitted to the hospital for further testing.
Her influenza A and B viral polymerase chain reaction (PCR)
tests were negative, as was her respiratory viral panel assay.
Blood cultures and hepatitis B and C serologies were negative.
Laboratory results (total bilirubin 1.8 mg/dl, direct bilirubin
0.3 mg/dl and lactate dehydrogenase 325 U/L on admission)
were concerning for hemolysis, and, given her history of tick
exposure, thick and thin blood smears were evaluated for
parasites. Giemsa staining demonstrated inclusion bodies in
the red blood cells, with a total parasitemia level of 0.07%. She
was also found to have a positive Lyme antibody, confirmed
with PCR. This overall clinical presentation was consistent
with Babesia (B. microti later confirmed with PCR) and Lyme
co-infection. She was prescribed atovaquone 750mg twice a day
for 10 days and azithromycin 250mg once a day for 10 days for
treatment of Babesiosis and doxycycline 100mg twice a day for
30 days to treat her Lyme disease. Two weeks after discharge she
had completed her antibiotic course, her strength had returned
to normal, and all her previous symptoms had resolved.

Case 2
A 44-year-old female from suburban Southeastern Pennsylvania
presented to TJUH with fevers and headache. Her past medical
history was significant for type 2 diabetes mellitus, obesity,
pancreatic mucinous cystic neoplasm of the tail of the pancreas
status post distal pancreatectomy and splenectomy 3 years ago.
The patient reported that intermittent fevers began 8 days prior
to presentation, but she was unsure of a pattern or cyclical
nature. She stated her temperature maximum at home was 103º
F. Her fevers were associated with intermittent headaches that
she described as “pounding” in quality and located both at the
back of her head and behind her eyes. She did not describe it as
the worst headache of her life. She had occasionally been taking
acetaminophen and ibuprofen with minimal to no relief of pain.
She denied abdominal pain, nausea, vomiting, and rash.
The patient reported travel one month prior to the mountains
of Northeastern Pennsylvania, where she spent a significant
amount of time outside in wooded areas. She denied finding
ticks or bite marks on her body, and had not had any rash since
that time. Travel history was also notable for a trip to North
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Carolina 6 months prior to admission and travel to China 10
years ago.
Physical examination was significant for fever with temperature
maximum of 103.1º F, tachycardia with heart rate 119 bpm, and
blood pressure 98/51 mmHg. Skin exam, including inspection of
scalp, revealed no rash. Examination was otherwise significant
for obesity. Pupils were equally round, reactive to light and
anicteric. Neurological examination revealed cranial nerves 2
through 12 to be intact. Motor function was grossly normal,
sensation intact throughout.
Laboratory studies revealed leukocytosis with bandemia,
thrombocytopenia and hemolysis. Electrolyte panel was within
normal limits. There was a slight transaminitis in a mixed
hepatocellular/cholestatic pattern. Given her headache and
fever, lumbar puncture was performed and cerebrospinal fluid
analysis was unremarkable. A preliminary review of blood smear
revealed intra-erythrocyte ring forms with an initial parasite
load of 18%. Polymerase chain reaction for Babesia microti
deoxyribonucleic acid was positive, confirming suspicion for
Babesia infection. Serology for HIV, Ehrlichia, Rocky Mountain
Spotted Fever, Rickettsia yphi, and anaplasmosis was negative.
Lyme immunoglobulin G and immunoglobulin M antibodies
were positive. The overall clinical picture was consistent with a
co-infection of both babesiosis and Lyme disease. Further, given
her relatively large parasite burden it was determined to treat
this patient as severe babesiosis.
Treatment plan included a course of clindamycin and quinine
for her severe babesiosis, as well as doxycycline to cover Lyme
disease. The patient’s blood parasite level was monitored, and
on the second hospital day it increased to 36% from 18%. In
response to this rapid rise in the parasite burden exchange
transfusion was implemented; she tolerated this procedure
without any complications. On the following day her parasite
load decreased to 0.07% and remained stable around this level.
Patient was deemed stable and discharged home to finish her
antibiotic regimen.

Blacklegged Tick
(Ixodes scapularis)

Figure 1. Areas inhabited by Ixodes scapularis. European
babesiosis, present in all states of Western Europe, involves a
different species of both Ixodes and Babesia, and classically
causes a much more severe disease
lactate dehydrogenase and indirect bilirubin); a subsequent thin
peripheral smear will display the characteristic intraerythrocytic
parasites (Figure 2). Interestingly, the pathognmonic “maltese
cross” sign (Figure 3) is a relatively rare formation but can be
appreciated if an erythrocyte is found when the parasite in an
asexual reproduction.
In select patients, progression to severe disease can be rapid
and can include disseminated intravascular coagulation,
acute respiratory distress syndrome, kidney and heart failure
and myocardial or splenic infarction. Risk factors for severe
disease include patient age > 50 years, immunocompromise,
co-infection with human immunodeficiency virus and, more
pertinent to our cases, previous splenectomy (Case 2) and
co-infection with Borrelia (both cases).10
Several sources corroborate the poor outcome associated with
asplenia, both functional or post-splenectomy.3,9,10,11 In their

Discussion
Babesiosis is an infectious disease caused by parasitic protozoa
of the genus Babesia. Human beings are only accidental hosts—
Babesia is normally maintained amongst rodent reservoirs
and dependent on the Ixodes scapularis tick for transmission.
As a result, infection typically involves residence in, or travel
to, locations common to the Ixodes tick: the Northeastern
and upper Midwestern United States (Figure 1). Most cases
are reported during the summer and spring months when the
protozoa is in its nymph or adult stage.2
Clinical manifestations follow an incubation period of 1-6
weeks and initially mimic an acute viral infection with gradual
onset of fever, fatigue and malaise. Unlike Lyme disease, there
is no rash associated with babesiosis. Laboratory evaluation
may reveal evidence of hemolysis (low haptoglobin, elevated
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Figure 2. Thin Geimsa smear of peripheral blood showing both
intra- and extraerythrocytic ring forms
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Krause et al reported a four-fold increase in new babesiosis
cases relative to Lyme disease in Rhode Island.6 Expansion of
human habitats into areas where the tick and rodent population
is high will likely lead to continued zoonotic infections, and thus
co-infection.

Figure 3. Disintegrated maltese cross
landmark study, White et al. showed that 10 of 16 (63%) patients
post-splenectomy experienced severe disease compared to only
42 of 121 (34%) patients in the control group.10 A European study
found that babesiosis almost exclusively affects those without
a functional spleen.7 The exact mechanism by which asplenia
contributes to severe disease has not yet been elucidated, but
Vannier et al suggest that the spleen allows for compartmentalization of the inflammatory reaction (largely IFN-γ and TNF-α
based) necessary to activate anti-protozoal macrophages. In the
absence of this compartmentalization, systemic inflammation
can develop. 9 The spleen is also necessary for removing
senescent and malformed erythrocytes. In malaria Plasmodium
falciparum manages to avoid widespread splenic removal of its
infected erythrocytes through cytoadherence (red blood cell
sequestration in the capillaries of distant organs).4 This process
has been demonstrated in Babesia bovis, but is not known to
occur in Babesia microti, and as a result the spleen may play a
much larger role in this disease response.9
Another risk factor for severe disease, co-infection with Borrelia
burgdorferi is also well- documented—unsurprising given that
up to 1 in 3 New Jersey ticks carry Borellia burgdorferi and 1
in 11 carry Babesia microti.1 In a recent study, 14 of 70 patients
(20%) with serologic evidence of babesiosis also had evidence
of Lyme disease. Co-infected patients experienced more severe
clinical manifestations and a longer duration of symptoms.5
While Borrelia remains the overall more common pathogen,
newer trends show that the incidence of Babesia is on the rise.
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It is important to assess for these risk factors because the presence
of severe disease changes the treatment paradigm. While mild
illness can be treated with a combination of azithromycin and
atovaquone, the recommendation for severe disease is paired
clindamycin (300-600mg IV every 6 hours) and quinine (650 mg
by mouth every 6 to 8 hours). Doxycycline (100 mg by mouth
every 12 hours) is added to cover confirmed Borrelia.11 Baseline
and follow-up electrocardiograms are important in trending
the corrected QT interval while on quinine. Daily hemoglobin,
hemolysis labs and blood parasite levels should be monitored
while the patient remains hospitalized. Significant hemolysis,
severe disease and/or parasitemia > 10% are all indications
to begin exchange transfusion therapy. 11 As clinical status
improves and parasite levels remain low, the transition can be
made to outpatient therapy. There are no specific guidelines for
the duration of therapy, but in Case 2, the patient was treated
with 2 weeks of clindamycin/quinine and 3 weeks of doxycycline
following documented parasite clearance.
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